Arcus Biosciences, Inc.
RCUS- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001724521
In the last 90 days, Arcus Biosciences, Inc. insiders filed 0 open-market purchases and 2 sales; 231 institutions reported holding it in 13F filings for Q2 2026, worth $3.78B in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Arcus Biosciences, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Of which not filed for Q3 2023 | Q3 2023 | Change |
|---|---|---|---|---|
| Holders | 181 | 2 | 187 | +8 |
| Shares | 54.7M | 666.9K | 52.8M | −1.23M (−2.3%) |
| Value | $1.11B | $13.5M | $947.9M | −$148.6M (−13.6%) |
2 institutions that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (31)
Institutions that held Arcus Biosciences, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
Sold out (23)
Institutions that held Arcus Biosciences, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Logos Global Management LP | 750,000 | $15.2M |
| Jump Financial, LLC | 63,921 | $1.30M |
| Kiwi Wealth Investments Limited Partnership | 55,409 | $1.13M |
| Moore Capital Management, LP | 40,000 | $812.4K |
| Centiva Capital, LP | 34,984 | $710.5K |
| Duality Advisers, LP | 29,050 | $590.0K |
| Occudo Quantitative Strategies LP | 28,783 | $584.6K |
| TD Asset Management Inc | 23,500 | $477.3K |
| Schroder Investment Management Group | 15,485 | $314.5K |
| CWM Advisors, LLC | 15,318 | $311.1K |
| Cetera Advisors LLC | 11,212 | $227.7K |
| Mutual of America Capital Management LLC | 10,281 | $208.8K |
| Teza Capital Management LLC | 10,157 | $206.3K |
| D. E. Shaw & Co., Inc. | 9,995 | $203.0K |
| Healthcare of Ontario Pension Plan Trust Fund | 5,000 | $101.5K |
| Cutler Group LP | 1,200 | $24.0K |
| Robeco Institutional Asset Management B.V. | 1,143 | $23.2K |
| Quantbot Technologies LP | 300 | $6.09K |
| C M Bidwell & Associates Ltd | 130 | $2.64K |
| Tucker Asset Management LLC | 50 | $1.02K |
| Impact Partnership Wealth, LLC | 37 | $751 |
| FinTrust Capital Advisors, LLC | 23 | $476 |
| Disciplined Investments, LLC | 4 | $81 |
Not filed for Q3 2023 yet (2)
Institutions that held Arcus Biosciences, Inc. at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Pictet Asset Management SA | 634,045 | $12.9M |
| Tekla Capital Management LLC | 32,839 | $667.0K |